Results 251 to 260 of about 70,014 (324)

A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias

Journal of Clinical Lipidology, 2013
OBJECTIVE: To investigate the influence of the silent mutation c.816C > G (L272) of Niemann-Pick C1-like 1 (NPC1L1) and of apolipoprotein (APO) E alleles on cholesterol absorption markers, sitosterol and campesterol, in 87 patients with primary ...
Livia Pisciotta, Stefano Bertolini, Matteo Pirro   +2 more
exaly   +3 more sources

Hyperlipidemias

Clinics in Dermatology, 1996
Glenn G. Russo
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Xanthomas and hyperlipidemias.

Journal of the American Academy of Dermatology, 1985
The ability to recognize diverse clinical forms of xanthomas, such as tuberous, planar, eruptive and tendinous, is important in the detection of underlying systemic disease. A variety of primary genetic disorders, as well as numerous secondary conditions such as diabetes, obstructive liver disease, thyroid disease, renal disease, and pancreatitis, can ...
Frank Parker
semanticscholar   +3 more sources

Therapy of the hyperlipidemias

Postgraduate Medicine, 1976
Although the diagnosis of hyperlipidemia is somewhat arbitrary, in that the upper limits of normal are not universally agreed upon, it is clear that the risk of atherosclerosis increases with plasma cholesterol concentration; it may also increase in hyperglyceridemia.
Robert S Lees, A M Lees
exaly   +3 more sources

Treatment of hyperlipidemias.

The American Journal of Medicine, 1968
Abstract The long-term effects of ethyl chlorophenoxyisobutyrate (CPIB), thyroid-active substances and diet were observed in seventy-two patients with five different types of hyperlipoproteinemias. Essential hypercholesterolemia (Sf 0–20 hyperlipoproteinemia) with tendon xanthomatosis proved refractory to CPIB, and to supplementary corn oil, but Sf 0 ...
E. Strisower, G. Adamson, Beverly Strisower   +2 more
semanticscholar   +3 more sources

Elevation of red cell sodium-lithium countertransport in hyperlipidemias.

Life Science, 1985
Red cell Na-Li countertransport was measured in 78 normal subjects, 64 patients with essential hypertension, and 67 patients with hyperlipidemias. Both hypertensive and hyperlipidemic patients had elevated Na-Li countertransport compared to normal ...
R. Corrocher, M. Steinmayr, O. Ruzzenente, C. Brugnara, L. Bertinato, M. Mazzi, Carla Furri, F. Bonfanti, Giorgio De Sandre   +8 more
semanticscholar   +3 more sources

Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption

Acta Diabetologica, 2011
Plant sterols lower serum cholesterol concentration. Available data have confirmed the lipid-lowering efficacy in adults, while there is a relative dearth of data in children and almost exclusively restricted to subjects with familial ...
O. Guardamagna, F. Abello, V. Baracco, Giorgio Federici, P. Bertucci, A. Mozzi, L. Mannucci, A. Gnasso, Claudio Cortese   +8 more
semanticscholar   +2 more sources

Management of Hyperlipidemias

JAMA: The Journal of the American Medical Association, 1974
The treatment of hyperlipidemia is desirable, especially in patients with a family history of premature ischemic heart disease, but only after the specific type of hyperlipoproteinemia has been determined. Secondary causes of hyperlipoproteinemia should be sought and eliminated.
Barbara F. Murphy
openaire   +3 more sources

Program on surgical control of the hyperlipidemias (POSCH): Recruitment experience

Contemporary Clinical Trials, 1987
Henry Buchwald, John P Matts, Laurie L Fitch   +2 more
exaly   +2 more sources

Classification of the Hyperlipidemias

Annual Review of Medicine, 1977
R J Havel
exaly   +3 more sources